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Edited by Vladimir SkulachevAbstract Apoptosis repressor with caspase recruitment domain
(ARC), an anti-apoptotic protein, is highly expressed in diﬀeren-
tiated heart and skeletal muscle. Apoptosis and diﬀerentiation
share numerous common pathways; therefore, we examined the
impact of ARC on H9c2-myoblast diﬀerentiation. We demon-
strate that ARC expression levels increase and stabilize upon
diﬀerentiation. ARC-overexpression in pre-diﬀerentiated H9c2-
cells suppresses diﬀerentiation; indicated by increased myotube
formation, nuclear fusion and expression of the diﬀerentiation
markers myogenin and troponin-T. ARC-overexpression inhib-
ited myoblast diﬀerentiation associated caspase-3 activation,
suggesting ARC inhibits myogenic diﬀerentiation through cas-
pase inhibition. In summary, we show a novel role for ARC in
the regulation of muscle diﬀerentiation.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Apoptosis repressor with caspase recruitment domain (ARC)
was originally discovered as a caspase-2 and -8-interacting,
anti-apoptotic protein that is expressed primarily in the heart
and skeletal muscle [1]. ARC is capable of preventing both
apoptotic and necrotic cell death by preserving mitochondrial
function [2]. More recently, work by Nam et al. [3] has sug-
gested that ARC is a unique protein that is capable of intersect-
ing with both the intrinsic and extrinsic apoptotic pathways.
Overexpression of ARC inhibits ischemia-induced apoptosis
in cardiomyoblast H9c2 cells by preventing mitochondrial
cytochrome c release [4] and, in Langendorﬀ-perfused rat
hearts, TAT-transduction of ARC was shown to signiﬁcantly
reduce infarct size following ischemia and reperfusion [5].
Recent studies suggest that apoptosis and diﬀerentiation
share common pathways in muscle cells [6–8], which raisesAbbreviations: ARC, apoptosis repressor with caspase recruitment
domain; DMEM, Dulbecco’s modiﬁed Eagle’s media; FCS, fetal calf
serum; HS, horse serum; RFU, relative ﬂuorescence units
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doi:10.1016/j.febslet.2007.01.050the possibility that ARC may also participate in the regulation
of muscle cell diﬀerentiation. Actin ﬁber disassembly and reor-
ganization are conserved features of both apoptosis and myo-
blast diﬀerentiation. Similarly, caspase activity is a key
component of both apoptosis and skeletal muscle diﬀerentia-
tion [6]. Caspase-3 inhibition reduces myotube/myoﬁber for-
mation as well as expression of muscle-speciﬁc proteins
during myogenesis [6]. Further, dysregulated myoblast diﬀer-
entiation and apoptosis in response to certain cytokines may
be associated with increased muscle wasting in chronic disease
states such as infection, acquired immune deﬁciency syndrome
and cancer [9]. Interestingly, tumor necrosis factor alpha, a
principle cytokine associated with cachexia, is involved in the
regulation of skeletal muscle diﬀerentiation and apoptosis [9].
Thus, it is exciting to speculate that proteins which inhibit both
diﬀerentiation and apoptosis could attenuate such degenera-
tive diseases by preventing muscle diﬀerentiation thereby facili-
tating further replication.
In this study, we examined alterations in native ARC expres-
sion following the induction of diﬀerentiation as well as the
eﬀect of ARC overexpression on muscle cell diﬀerentiation
using H9c2 rat myoblasts as a model. We demonstrate that
ARC expression is increased in diﬀerentiated cells and we
show, for the ﬁrst time, that ARC overexpression prevents
myoblast diﬀerentiation. Taken together, these results provide
evidence of a novel bi-functional role for the apoptosis regula-
tory protein ARC in myoblast diﬀerentiation.2. Materials and methods
2.1. Cell culture, stable transfection, and diﬀerentiation
The rat embryonic cardiac cell line H9c2 was obtained from the
American Type Culture Collection (Manassas, VA). They were grown
and maintained in Dulbecco’s modiﬁed Eagle’s media (DMEM) supple-
mented with 10% fetal calf serum (FCS). Stable transfection with
pcDNA3-Neo or pcDNA3-ARC was carried out using lipofectamine
as previously described resulting in the production of Neo transfected
cells and two clones, L5 and L24, which express high levels of ARC
[17].Muscle diﬀerentiation was induced by replacingDMEMcontaining
10%FCSwith 1% horse serum (HS) when cells were conﬂuent. Diﬀeren-
tiation was quantiﬁed by determining the number of diﬀerentiated cells
which were showed at least three nuclei and expressed as a percentage
of the total number of nuclei in 10 randomly chosen microscopic ﬁelds.
2.2. Cell viability
H9c2-Neo or ARC stable cell lines, L5 and L24, were treated with 0–
500 lM H2O2 for 8 h. Cell viability was assessed using the calcein-AMblished by Elsevier B.V. All rights reserved.
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880 A.L. Hunter et al. / FEBS Letters 581 (2007) 879–884cell viability assay (Molecular Probes, Eugene, OR). Brieﬂy, calcein-
AM was added to cells at a ﬁnal concentration of 5 lM. Fluorescence
intensity was read following 1 h of substrate incubation (excitation
485 nm; emission, 527 nm).
2.3. Western blot analysis
Equal amounts of protein were separated by sodium dodecyl sul-
phate–polyacrylamide gel electrophoresis and then transferred to nitro-
cellulose membranes. After blocking, the membranes were incubated
for 1 h with primary antibodies (1:1000 anti-myogenin antibody and
1:200 anti-skeleton muscle troponin-T antibody (Santa Cruz Biotech-
nology, Santa Cruz, CA) or 1:1000 anti-ARC antibody (Alexis Co.,
Lausen, Switzerland)), followed by incubation for 1 h with 1:4000 IR-
Dye800 or 1:2000 IRDye700-conjugated secondary antibodies
(Rockland Inc., Gilbertsville, PA). Protein expression was detected by
using the Odyssey Infrared Imaging System from LI-COR Biosciences
(Lincoln, NE).
2.4. Immunostaining
At day 5 post-diﬀerentiation, H9c2 cells transfected with ARC or
vector alone were stained with AlexaFluor 488-labelled phalloidin
and Hoechst 33342 (Molecular Probes, OR) to visualize F-actin and
nuclei, respectively. Cells were imaged using a Nikon microscope
and Spot digital camera.
2.5. DEVDase activity assay
DEVDase activity assays were performed to detect caspase-3/7-like
activity, as described previously [10,11]. At day 0, 1, 3 and 5 post-dif-
ferentiation, H9c2 cells transfected with ARC or vector alone were
lysed in whole cell lysis buﬀer (1% NP-40, 20 mM Tris, pH 8,
137 mM NaCl, 10% glycerol, 1 mM phenylmethyl sulfoxide,
0.15 U/ml aprotinin, and 1 mM sodium orthovanadate). Lysates
(0.3 mg/ml) or buﬀer as control were plated in triplicate and incubated
at 37 C for 15 min. Acetyl-DEVD-7-amino-4-methylcoumarin
(Ac-DEVD-AMC) (37.5 mg/ml, Calbiochem) caspase-3 substrate was
added and relative ﬂorescence units (RFU) were measured after 2 h
at 37 C using a ﬂuorescence plate reader (ex: 380 nm, em: 460 nm).Fig. 1. ARC levels increase in H9c2 cells upon diﬀerentiation and
overexpression of ARC prevents H2O2-induced cell death. (A) Immu-
nostaining of ARC at day 0, 3 and 5 following the induction of
diﬀerentiation. The same blot was stained with an antibody against b-
actin to illustrate equal protein loading. (B) ARC stable cell lines, L5
and L24, express high levels of ARC. (C) H9c2-Neo and ARC cells
were treated with various concentrations of H2O2 and cell viability was
assessed using the calcien-AM cell viability assay at 8 h post-treatment.
Values are expressed as the percent viability the test group compared
to that of untreated H9c2-Neo cells. Bars represent the means ± S.E.
(n = 3), * = P-value < 0.05.3. Results
3.1. ARC expression during diﬀerentiation
Initial examination involved evaluating the native expression
levels of ARC throughout H9c2 cell diﬀerentiation. Diﬀerenti-
ation was induced by growing cells to conﬂuency and replacing
DMEM containing 10% FCS with DMEM containing 1% HS.
ARC was undetectable in undiﬀerentiated H9c2 cells. How-
ever, ARC expression rose to detectable levels by day 3 follow-
ing diﬀerentiation and by day 5 ARC levels had reached
maximal and sustained expression levels (Fig. 1A).
3.2. Functional overexpression of ARC in H9c2 cells
H9c2 cell lines stably overexpressing ARC or Neo (control)
were created by selecting clones from pcDNA3 transfected
cells. Two clones, L5 and L24, were selected due to their high
expression levels of ARC (Fig. 1B). Both clones were used in
subsequent analyses in order to reduce the possibility that
the eﬀects observed are resulting from a gene disruption as a
consequence of vector integration into the host cell genome
rather than from the overexpression of ARC. The functional-
ity of ARC was conﬁrmed in these cells lines by examining cell
viability following exposure to hydrogen peroxide (Fig. 1C).
H9c2-Neo control cells demonstrated dose dependent loss in
viability after 8 hours of treatment with H2O2 doses between
0 and 500 lM. The H9c2-ARC clones, L5 and L24, demon-
strated a signiﬁcant anti-apoptotic eﬀect at all H2O2 concentra-
tions (P-values < 0.05) and were able to maintain cell viability;showing a slight decrease in viability at only the highest con-
centration of 500 lM (73.94 ± 4.15% for L5, 82.53 ± 12.50%
for L24, compared to 41.09 ± 3.98% of Neo cells; expressed
as means ± S.E.).3.3. Characterization of H9c2-ARC cell diﬀerentiation
We next examined the role of ARC overexpression in myo-
tube diﬀerentiation. Cells were visualized at 0, 3 and 5 days
after the induction of diﬀerentiation. H9c2-Neo cells demon-
strated myoblast elongation/diﬀerentiation; however, elonga-
tion was attenuated in H9c2-ARC cells (Fig. 2A). Elevated
myotube disarray and disorganization were observed at day
3 and 5 in the ARC overexpressing cells compared that of
the H9c2-Neo cells. In addition to myotube elongation,
multi-nucleation was also observed in the H9c2-Neo at a rate
of 11.24 ± 5.05%, but was absent in the H9c2-ARC cells (Figs.
2B and C).
To further assess the inﬂuence of ARC overexpression on
myoblast diﬀerentiation, the status of muscle speciﬁc proteins
Fig. 2. Overexpression of ARC prevents myogenic diﬀerentiation. (A) Representative morphological changes of ARC stable cell lines, L5 and L24, at
day 0, 3 and 5 following the induction of diﬀerentiation. (B) Immunostaining of ARC overexpressing H9c2 cells at day 5 post-diﬀerentiation. H9c2
cells transfected with ARC, or vector alone were stained with AlexaFluor 488-labelled phalloidin for F-actin (red). Cell nuclei were counterstained
with Hoechst (blue). Arrows indicate multi-nucleated cells. (C) Myogenic diﬀerentiation was quantiﬁed by the number of diﬀerentiated cells which
were showed at least three nuclei and expressed as a percentage of the total number of nuclei in 10 randomly chosen microscopic ﬁelds. The results
shown are means ± standard deviation (n = 10) and signiﬁcance was determined by Student’s t test.
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ponin-T were both highly expressed in diﬀerentiated (Day 3
and 5 post-diﬀerentiation) H9c2-Neo cells but were minimally
detectable in the ARC-overexpressing, L5 and L24, H9c2 cell
lines (Fig. 3A). Consistent with these ﬁndings, when H9c2-
Neo cells were transiently transfected with an adenovirus
ARC construct, the muscle diﬀerentiation markers were signif-
icantly reduced (Fig. 3B).
3.4. Caspase-3 activation during H9c2 diﬀerentiation
To examine whether caspase-3 is activated during myotube
diﬀerentiation, we measured caspase-3 activity by the cleavage
of Ac-DEVD-AMC substrate. As shown in Fig. 4, at day 0post-diﬀerentiation, caspase-3 activity was not diﬀerent between
Neo and ARC overexpressing cells (Neo: 4400 ± 504 RFU,
ARC: 4192 ± 2672 RFU; expressed as means ± S.D.). However
at day 1 post-diﬀerentiation caspase-3 activity signiﬁcantly in-
creased in the Neo cells, implying an important role of caspase
activation in cell diﬀerentiation. Overexpression of ARC
prevented caspase-3 activation at day 1 post-diﬀerentiation
(16108 ± 1135 RFU for ARC cells compared to 39736 ± 1796
RFU for Neo cells). By day 3 post-diﬀerentiation caspase-3
activity levels decreased in both groups (Neo: 10505 ± 694
RFU, ARC: 14861 ± 1928 RFU) and were relatively stable
through to day 5 (Neo: 10303 ± 624 RFU, ARC: 10390 ±
1707 RFU).
AB
-Troponin-T
-Myogenin
-β-actin
Neo    L5     L24 Neo    L5     L24 Neo    L5     L24
Day 0 Day 3 Day 5
-ARC
Day 0 Day 3 Day 5
-ARC
-Troponin-T
-Myogenin
-β-actin
A
d-
G
FP
A
d-
AR
C
A
d-
G
FP
A
d-
AR
C
A
d-
G
FP
A
d-
AR
C
Fig. 3. ARC overexpression prevents the expression of the muscle-speciﬁc markers troponin-T and myogenin. At day 0, 3 and 5 post-diﬀerentiation,
cell lysates were collected and Western blotting was performed to determine troponin-T, myogenin and ARC expression. The same blots were stained
with an antibody against b-actin to illustrate equal protein loading. The data are representative of three diﬀerent experiments from stably transfected
cells (A) or transiently transfected cells (B).
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
Day 0 Day 1 Day 3 Day 5
D
EV
D
as
e
ac
tiv
ity
Neo
ARC
P<0.005
Fig. 4. Caspase activity increases during myoblast diﬀerentiation. At
day 0, 1, 3, and 5 post-diﬀerentiation, cell lysates were harvested and
caspase activity assay was determined. The data shown are
means ± standard deviation (n = 3) and signiﬁcance was determined
by Student’s t test.
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Apoptosis is a critical physiological process that is essential
for normal tissue development and homeostasis. Dysregula-
tion of this form of cell death is associated with numerous
pathological conditions. Apoptosis has been shown to play a
vital role in skeletal myoblast diﬀerentiation [6,7,12–14]. As
such, we were interested in the role of ARC in the regulation
of myocyte diﬀerentiation. H9c2 myoblasts, isolated from ratembryonic cardiomyocytes, proliferate under normal condi-
tions and are mono-nucleated. This cell line is also a well char-
acterized model of diﬀerentiation. When H9c2 cells are
exposed to reduced serum concentrations at conﬂuence, they
fuse and diﬀerentiate into elongated, multi-nucleated myotu-
bes [15]. Although this cell line exhibits some diﬀerences from
primary cells, H9c2 cells share many of the properties of pri-
mary cardiomyoblasts and skeletal muscle [15–18] and can
be easily propagated and stably transfected, making them an
ideal model for this study.
ARC is highly expressed in terminally diﬀerentiated cardiac
and skeletal muscle cells [1]. However, we were unable to de-
tect ARC expression in undiﬀerentiated H9c2 rat myoblast
cells leading us to ask questions regarding the regulation of
ARC expression during myoblast diﬀerentiation and the
importance of this regulation on the diﬀerentiation process.
ARC expression increased by day 3 following diﬀerentiation
and reached maximal and sustained levels by day 5. To under-
stand whether regulation of ARC expression during diﬀerenti-
ation is important to the process of diﬀerentiation itself, we
examined the eﬀect of ARC overexpression using pre-diﬀeren-
tiated H9c2 cells. H9c2 cells overexpressing ARC were unable
to diﬀerentiate as indicated by morphological characteristics
such as myotube elongation and multinucleation.
Myogenic diﬀerentiation, characterized by cell growth arrest,
myoblast alignment, elongation, and fusion of mono-nucleated
myoblasts into multi-nucleated myotubes, is dependent on the
expression of the MyoD family of basic helix–loop–helix tran-
A.L. Hunter et al. / FEBS Letters 581 (2007) 879–884 883scription factors, which includes MyoD, Myf5, myogenin, and
MRF4 [19]. Upon stimulation, myoblasts induce the expression
of the muscle regulatory factors, which in turn leads to the
expression of muscle-speciﬁc genes. To further assess the inﬂu-
ence of ARC overexpression on myoblast diﬀerentiation, the
status of muscle speciﬁc proteins myogenin and troponin-T
were evaluated. Myogenin and troponin-T were both highly
expressed in diﬀerentiated (day 3 and 5 post-diﬀerentiation)
H9c2-Neo cells but were minimally detectable in the ARC-
overexpressing, L5 and L24, H9c2 cell lines (Fig. 3A). These re-
sults were conﬁrmed using H9c2-Neo cells that were transiently
transfected with an adenovirus ARC construct. Thus, inhibi-
tion of ARC expression is vital for the proper diﬀerentiation
of these cells. Whether premature ARC expression culmi-
nates in abnormal cardiovascular development is unclear and
requires further investigation.
Recent studies have suggested that caspase-3 activity is re-
quired for skeletal muscle diﬀerentiation [6]. As ARC inhibits
caspase mediated apoptosis, we examined whether caspase-3 is
activated during myotube diﬀerentiation and whether overex-
pression of ARC prevents that activation. Caspase-3 activity
signiﬁcantly increased at day 1 post-diﬀerentiation and ARC
overexpression prevented caspase activation. As ARC does
not interact directly with caspase-3, it is likely modifying cas-
pase-3 activation through its interactions with caspase-2, 8 or
the Bcl-2 protein Bax as has previously been shown [3,20].
These ﬁndings suggest that ARC expression must be attenu-
ated or absent to allow for early diﬀerentiation events includ-
ing caspase-3 activation and that it is at this early stage of
diﬀerentiation during which ARC impacts the diﬀerentiation
process. Our initial ﬁnding that ARC is endogenously
expressed at undetectable levels until day 3 post-diﬀerentiation
(i.e. after caspase-3 is activated) supports this hypothesis.
Therefore, the inhibition of diﬀerentiation markers, such as
myogenin and troponin-T, in the ARC overexpressing cell
lines are likely a result of these upstream events. This hypoth-
esis would explain why endogenous expression of ARC at day
3 and day 5 does not prevent diﬀerentiation. The induction of
ARC following caspase-3 activation would likely be beneﬁcial
as it may protect properly diﬀerentiating cells from apoptosis.
It is becoming increasingly more apparent that ARC is a
multi-faceted anti-apoptotic protein. Several mechanisms have
been proposed as to how ARC attenuates apoptosis including:
inhibition of caspases, mitochondrial membrane depolariza-
tion, death inducing signaling complex formation, Bax activa-
tion, and cytochrome c release or K+ currents [1–5,21]. The
results of this study demonstrate a novel role for ARC in myo-
blast diﬀerentiation and suggest that ARC expression is tightly
controlled throughout the diﬀerentiation process in order to
allow for initiating events such as caspase-3 activity.
The challenge for future studies will be to further delineate
the detailed mechanisms by which ARC’s expression is regu-
lated and contributes to myocyte diﬀerentiation as well as
the potential role of ARC in myocyte disarray and disease. Re-
duced troponin-T expression, which we have shown can be in-
duced by ARC expression during diﬀerentiation, contributes
to myocyte disarray [14] and mutations in this gene are associ-
ated with myocyte disarray and 15% of all cases of familial
hypertrophic cardiomyopathy [22]. Myoﬁbrillar disarray is
also commonly associated with familial hypertrophic cardio-
myopathy, the leading cause of sudden death in young ath-
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